Ensysce Biosciences, Inc.
Ensysce Biosciences, Inc. (ENSC) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · ENSC · as of Jun 8, 2026
Activity summary
Buy transactions
5
P-Purchase only
Sell transactions
0
12 Months
Buy/Sell ratio
∞
Buy/Sell (by trades)
Overall sentiment
Ensysce Biosciences, Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
ENSC insider buying and selling by quarter
ENSC insider selling · ENSC insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Recent insider transactions
ENSC executive sell shares · ENSC board member insider trading · ENSC insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Mar 2, 2023 | GOWER BOB G Director | Purchase | 90,287 | $44K | Form 4 |
| Mar 1, 2023 | GOWER BOB G Director | Purchase | 270,000 | $129K | Form 4 |
| Feb 28, 2023 | GOWER BOB G Director | Purchase | 109,300 | $53K | Form 4 |
| Dec 9, 2022 | GOWER BOB G Director | Purchase | 357,143 | $500K | Form 4 |
| May 25, 2022 | Kirkpatrick Lynn CEO | Purchase | 27,000 | $14K | Form 4 |
| Jun 30, 2021 | Humphrey David Carl CFO | Award | 50,000 | — | Form 4 |
| Jun 30, 2021 | Chang William H Director | Award | 2,242,189 | — | Form 4 |
| Jun 30, 2021 | Chang William H Director | Award | 353,451 | — | Form 4 |
| Jun 30, 2021 | GOWER BOB G Director | Award | 7,919,026 | — | Form 4 |
| Jun 30, 2021 | Kirkpatrick Lynn CEO · Director | Award | 284,851 | — | Form 4 |
| Jun 19, 2020 | MORGAN STANLEY 10 percent owner | Sale | 776,290 | $8.10M⚡ | Form 4 |
| Dec 1, 2017 | HG Vora Capital Management, LLC 10 percent owner | Purchase | 1,000,000 | $10.00M⚡ | Form 4 |
| Jan 15, 2018 | HG Vora Capital Management, LLC 10 percent owner | Other | 375,000 | — | Form 4 |
| Jan 15, 2018 | WEIL A LORNE Executive Chairman · Director | Other | 132,158 | — | Form 4 |
| Jan 15, 2018 | WEIL A LORNE Executive Chairman · Director | Other | 40,645 | — | Form 4 |
| Jan 15, 2018 | Peng George CFO | Other | 13,251 | — | Form 4 |
| Jan 15, 2018 | Carrera Eric SVP | Other | 8,330 | — | Form 4 |
| Jan 15, 2018 | Silvers Daniel B. CEO · Director | Other | 171,832 | — | Form 4 |
| Dec 5, 2017 | Silvers Daniel B. CEO · Director | Other | 359,869 | — | Form 4 |
| Dec 5, 2017 | WEIL A LORNE Executive Chairman · Director | Other | 169,517 | — | Form 4 |
| Dec 5, 2017 | WEIL A LORNE Executive Chairman · Director | Other | 187,166 | — | Form 4 |
| Dec 5, 2017 | HG Vora Capital Management, LLC 10 percent owner | Other | 718,750 | — | Form 4 |
| Dec 5, 2017 | Carrera Eric SVP | Other | 1,465 | — | Form 4 |
| Dec 5, 2017 | Peng George CFO | Other | 733 | — | Form 4 |
MORGAN STANLEY
10 percent owner
Date
Jun 19
Shares
776,290
Price
$10.44
Value
$8.10M ⚡
HG Vora Capital Management, LLC
10 percent owner
Date
Dec 1
Shares
1,000,000
Price
$10.00
Value
$10.00M ⚡
HG Vora Capital Management, LLC
10 percent owner
Date
Jan 15
Shares
375,000
Price
—
Value
—
WEIL A LORNE
Executive Chairman · Director
Date
Jan 15
Shares
132,158
Price
—
Value
—
WEIL A LORNE
Executive Chairman · Director
Date
Jan 15
Shares
40,645
Price
—
Value
—
WEIL A LORNE
Executive Chairman · Director
Date
Dec 5
Shares
169,517
Price
—
Value
—
WEIL A LORNE
Executive Chairman · Director
Date
Dec 5
Shares
187,166
Price
—
Value
—
HG Vora Capital Management, LLC
10 percent owner
Date
Dec 5
Shares
718,750
Price
—
Value
—
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About ENSC insider trading
ENSC insider trades
Ensysce Biosciences, Inc. (ENSC) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including ENSC. Over the past 12 months, 0 insiders have filed transactions with the SEC. ENSC insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Ensysce Biosciences, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
ENSC insider trading · 5 questionsThe insiders of Ensysce Biosciences, Inc. (ENSC) include executives and directors such as ENSC, among others. Over the past 12 months, 0 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026